298 related articles for article (PubMed ID: 15155566)
21. A comparative study of fibrillation kinetics of two homologous proteins under identical solution condition.
Chaudhary AP; Vispute NH; Shukla VK; Ahmad B
Biochimie; 2017 Jan; 132():75-84. PubMed ID: 27825804
[TBL] [Abstract][Full Text] [Related]
22. Effect of the structure of the denatured state of lysozyme on the aggregation reaction at the early stages of folding from the reduced form.
Ohkuri T; Shioi S; Imoto T; Ueda T
J Mol Biol; 2005 Mar; 347(1):159-68. PubMed ID: 15733925
[TBL] [Abstract][Full Text] [Related]
23. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line.
Ruiz ED; Almada M; Burboa MG; Taboada P; Mosquera V; Valdez MA; Juárez J
Colloids Surf B Biointerfaces; 2015 Feb; 126():335-43. PubMed ID: 25618793
[TBL] [Abstract][Full Text] [Related]
24. Oxidative refolding of amyloidogenic variants of human lysozyme.
Wain R; Smith LJ; Dobson CM
J Mol Biol; 2005 Aug; 351(3):662-71. PubMed ID: 16023673
[TBL] [Abstract][Full Text] [Related]
25. Physical basis for the ofloxacin-induced acceleration of lysozyme aggregation and polymorphism in amyloid fibrils.
Muthu SA; Mothi N; Shiriskar SM; Pissurlenkar RR; Kumar A; Ahmad B
Arch Biochem Biophys; 2016 Feb; 592():10-9. PubMed ID: 26777461
[TBL] [Abstract][Full Text] [Related]
26. Site-specific hydrogen exchange of proteins: insights into the structures of amyloidogenic intermediates.
Yao ZP; Tito P; Robinson CV
Methods Enzymol; 2005; 402():389-402. PubMed ID: 16401516
[TBL] [Abstract][Full Text] [Related]
27. Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution.
Goda S; Takano K; Yamagata Y; Nagata R; Akutsu H; Maki S; Namba K; Yutani K
Protein Sci; 2000 Feb; 9(2):369-75. PubMed ID: 10716189
[TBL] [Abstract][Full Text] [Related]
28. Aggregates with lysozyme and ovalbumin show features of amyloid-like fibrils.
Sugimoto Y; Kamada Y; Tokunaga Y; Shinohara H; Matsumoto M; Kusakabe T; Ohkuri T; Ueda T
Biochem Cell Biol; 2011 Dec; 89(6):533-44. PubMed ID: 22004604
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of the structural, dynamic and aggregation properties of the W64R amyloidogenic variant of human lysozyme.
Vettore N; Moray J; Brans A; Herman R; Charlier P; Kumita JR; Kerff F; Dobson CM; Dumoulin M
Biophys Chem; 2021 Apr; 271():106563. PubMed ID: 33640796
[TBL] [Abstract][Full Text] [Related]
30. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
Lindgren M; Sörgjerd K; Hammarström P
Biophys J; 2005 Jun; 88(6):4200-12. PubMed ID: 15764666
[TBL] [Abstract][Full Text] [Related]
31. Lysozyme: a paradigmatic molecule for the investigation of protein structure, function and misfolding.
Merlini G; Bellotti V
Clin Chim Acta; 2005 Jul; 357(2):168-72. PubMed ID: 15913589
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
Kumar S; Mohanty SK; Udgaonkar JB
J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
[TBL] [Abstract][Full Text] [Related]
33. Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants.
Dumoulin M; Kumita JR; Dobson CM
Acc Chem Res; 2006 Sep; 39(9):603-10. PubMed ID: 16981676
[TBL] [Abstract][Full Text] [Related]
34. Protein interactions and misfolding analyzed by AFM force spectroscopy.
McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
[TBL] [Abstract][Full Text] [Related]
35. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH.
Ookoshi T; Hasegawa K; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H
Nephrol Dial Transplant; 2008 Oct; 23(10):3247-55. PubMed ID: 18467373
[TBL] [Abstract][Full Text] [Related]
36. Simulations of human lysozyme: probing the conformations triggering amyloidosis.
Moraitakis G; Goodfellow JM
Biophys J; 2003 Apr; 84(4):2149-58. PubMed ID: 12668424
[TBL] [Abstract][Full Text] [Related]
37. In vitro investigation of the effect of mesalazine on amyloid fibril formation of hen egg-white lysozyme and defibrillation lysozyme fibrils.
Faramarzian M; Bahramikia S; Dehghan Shasaltaneh M
Eur J Pharmacol; 2020 May; 874():173011. PubMed ID: 32067935
[TBL] [Abstract][Full Text] [Related]
38. Anti-amyloidogenic and fibril-destabilizing effects of two manganese-salen derivatives against hen egg-white lysozyme aggregation.
Bahramikia S; Yazdanparast R
Int J Biol Macromol; 2012 Jan; 50(1):187-97. PubMed ID: 22061184
[TBL] [Abstract][Full Text] [Related]
39. High hydrostatic pressure dissociates early aggregates of TTR105-115, but not the mature amyloid fibrils.
Dirix C; Meersman F; MacPhee CE; Dobson CM; Heremans K
J Mol Biol; 2005 Apr; 347(5):903-9. PubMed ID: 15784251
[TBL] [Abstract][Full Text] [Related]
40. In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme.
Griffin JWD; Bradshaw PC
BMC Struct Biol; 2018 Jul; 18(1):9. PubMed ID: 30029603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
